Cointime

Protego Biopharma

company

About

Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy.

  • San Diego,California,United States
  • 1 - 10

Highlights

Total Funding Amount
$51.04M
Funding Rounds
1
Investors
3
Employee Profiles
4

Details

Last Funding Type
Series A
Last Funding Money Raised
$51.04M
Industries
Biopharma,Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active
Also Known As
Misfolding Diagnostics, Inc.

Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$51.04M
Protego Biopharma has raised a total of $51.04M in funding over 2 rounds. Their latest funding was raised on Oct 19, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 19, 2021 Series A $51.04M 3 Lightspeed Venture Partners
MPM Capital
Vida Ventures 		— Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Protego Biopharma is funded by 3 investors. Lightspeed Venture Partners and MPM Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Lightspeed Venture Partners Yes Series A
MPM Capital Yes Series A
Vida Ventures Yes Series A

Employee Profiles

Number of Employee Profiles
4
Protego Biopharma has 4 current employee profiles, including Board member Shelley Chu
Shelley Chu
Board member
Ed Hurwitz
Board member
Helen S. Kim
Board member
Cointime
Chủ Đề
Công Ty